AIDP announces a new published study for PureMune®, the patented
beta-glucan from Immudyne Nutritional
AIDP, Inc. announces a new published pilot study on PureMune®, a patented beta-glucan from its partner Immudyne Nutritional (Jacksonville, FL).
Researchers found that 30mg daily of PureMune consistently stimulated the production of immune cells, significantly increasing the levels of interferon-gamma (IFN-γ), interleukin-2 (IL-2) and the IFN-